Chest Pain in the Office
From May 2018, The Buzz That Won't QuitWhile chest pain in the outpatient setting is most commonly due to gastrointestinal, musculoskeletal, or “nonspecific” causes, primary care providers need to assess the likelihood of underlying cardiac disease quickly and effectively. Putting together clues from the history and physical exam …
28min 28Heidi James, MD and Spencer Blackman, MD
Paper Chase #2 | Sudden Cardiac Arrest during Competitive Sports
From February 2018, The Tragically Sore HipSudden cardiac death occurs rarely in competitive sport. This study showed that arrythmia is a more common cuase of SCD than structural heart disease in competitive athletes.
4min 56Andrew Buelt, DO and Joe Weatherly, DO
Paper Chase #1 | Fats and Carbs and Cardiovascular Disease
From February 2018, The Tragically Sore HipHigh carbohydrate intake was associated with higher risk of total mortality, whereas total fat and individual types of fat intake was related to lower total mortality
7min 6Joe Weatherly, DO and Andrew Buelt, DO
Paper Chase #3 | AC Use and Risk of Ischemic Stroke and Bleeding
From February 2018, The Tragically Sore Hipin patients who develop afib secondary to another medical condition like COPD or ACS, this study demonstrates that the benefit of anticoagulation in not strong and can be associated with a higher risk of bleeding.
5min 19Andrew Buelt, DO and Joe Weatherly, DO
Paper Chase #5 | Concerning a Cholesterol Drug We’ve Never Heard Of: Anacetrapib
From January 2018, A Feverish Frenzy!Dollars to donuts, the CETP inhibitors like anacetrapib are not part of your primary care pharmacologic arsenal. And this study shows why they never will be.
5min 8Andrew Buelt, DO and Joe Weatherly, DO
Paper Chase #3 | The COMPASS Trial
From January 2018, A Feverish Frenzy!Adding Rivaroxaban to aspirin therapy resulted in 1% fewer composite cardiovascular outcomes, but cause a 1% increase in bleeds. Andrew and Joe conclude that Rivaroxaban does not offer benefits above aspirin alone in the study population.
5min 47Andrew Buelt, DO and Joe Weatherly, DO
New Hypertension Guidelines: Friend, Foe, or Foolishness??
From December 2017, New Hypertension Guidelines: Friend, Foe, or Foolishness??Andrew and Heidi discuss the new AHA Hypertension guidelines that were released in November. Spoiler: even though they try really, really, REALLY hard to keep an open mind, our intrepid podcasters are not impressed. •
9min 11Heidi James, MD and Andrew Buelt, DO
Stuff that Changed our Practices, Part 2
From December 2017, Jingle, JingleHeidi talks about an online cardiovascular risk calculator that revitalized her approach to dyslipidemia management. She also covers the recent CDC and Health Canada guidelines on opioid prescribing. Jordan, who in the throes of a huge concussion trial he’s working on, focusses his attention …
11minHeidi James, MD, Brandon Grove, MD, and Jordan Roberts, PA-C
Stuff that Changed our Practices, Part 1
From December 2017, Jingle, JingleHeidi talks about an online cardiovascular risk calculator that revitalized her approach to dyslipidemia management. She also covers the recent CDC and Health Canada guidelines on opioid prescribing. Jordan, who in the throes of a huge concussion trial he’s working on, focusses his attention …
10min 39Heidi James, MD, Brandon Grove, MD, and Jordan Roberts, PA-C
Santa’s Health (Obesity, Soot Wart, Stress and OSA)
From December 2017, Jingle, JingleSanta Claus is not a healthy fellow! Andrew and Heidi stuff your stockings with brief updates on obesity, high sugar diets, soot wart, lung cancer screening, effect of long work hours, cardiovascular risks of stimulants and surgery for OSA.
12min 12Heidi James, MD and Andrew Buelt, DO
Bridging Anticoagulation
From November 2017, Lytes and BitesAndrew and cardiologist Dr. Paul Vaikus discuss bridging oral anticoagulation in several clinical contexts (peri-operative, anticoagulation initiation in thrombosis, anticoagulation initiation in atrial fibrillation). Current evidence does not support routine bridging with parenteral …
13min 44Paul Vaikus, MD and Andrew Buelt, DO
Paper Chase #3 - Cognitive Function in a Randomized Trial of Evolocumab
From November 2017, Lytes and BitesThis 19 month trial did not find any clinically significant changes in cognitive functioning in patients taking evolucomab compared to placebo. •
5min 14Andrew Buelt, DO and Joe Weatherly, DO
A Ghoulish Update
From October 2017, It's Bloody Halloween!Andrew and Heidi talk about the potential role of ASA in preventing colorectal cancer, compare fracture risks associated with common anticoagulants, and go on a bit of a tirade about lung cancer screening. •
12min 13Heidi James, MD and Andrew Buelt, DO
Paperchase #3 - CV testing and Outcomes in Chest Pain
From October 2017, It's Bloody Halloween!Our paperchasers looked at this study and concluded that exercise stress testing is overused in the low risk chest pain patient who has no EKG changes and no troponin rise. •
6min 4Andrew Buelt, DO and Joe Weatherly, DO
Paper Chase 2 - Evolocumab and CV Disease
From July 2017, Be Kind and Enjoy LifeThis is crazy expensive drug will lower your LDL to crazy low levels. But does it actually make a difference in mortality? •
5min 8Andrew Buelt, DO and Joe Weatherly, DO
Paper Chase 4 - Testosterone Treatment & Coronary Plaque
From June 2017, Legions of LesionsThis studied showed an increase in soft coronary artery plaque volume after 1 year of testosterone supplementation. A surrogate end point, yes, but there is an association between soft plaque volume and coronary artery disease. •
3min 47Andrew Buelt, DO and Joe Weatherly, DO
Paper Chase 3: Caffeine and Cardiac Arrhythmias in Patients With Heart Failure
From March 2017, The Benzos & Fungus Among UsIn this study population of patients with heart failure, caffeine consumption was not associated with cardiac arrhythmias. •
5min 53Andrew Buelt, DO and Joe Weatherly, DO
The Primary Care RAP Hot Sheet: January 2017
From January 2017, The Primary Care RAP Hot Sheet: January 2017What do Princess Leia, peanut butter, price-gouging and Ebola have in common? This Month’s Hot Sheet, of course! •
5min 9Heidi James, MD and Andrew Buelt, DO
Paper Chase 2 - How Much Kidney Disease Is There?
From January 2017, Bones Lose Their AutonomyAt a median of 10 years, prostate-cancer–specific mortality was low, irrespective of the treatment assigned, with no significant difference among treatments. •
5min 42Andrew Buelt, DO and Joe Weatherly, DO
The Primary Care RAP Hot Sheet: December 2016
From December 2016, The Primary Care RAP Hot Sheet: December 2016Andrew and Heidi talk about medical marijuana legislation, new statin guidelines, and the diabetes drug that has everyone talking.
5min 55Andrew Buelt, DO and Heidi James, MD
‹ PreviousNext ›